vs
NL INDUSTRIES INC（NL）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是NL INDUSTRIES INC的1.9倍（$69.8M vs $37.7M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs -82.2%，领先466.2%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs -1.9%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs -0.4%）
NL工业公司前身为国民铅业公司，是一家铅冶炼企业，目前总部位于美国得克萨斯州休斯顿。该企业历史底蕴深厚，早在1896年5月26日道琼斯工业平均指数创立之初，NL工业就是最初纳入指数的12只成分股之一。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
NL vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.9倍
$37.7M
营收增速更快
RIGL
高出23.1%
-1.9%
净利率更高
RIGL
高出466.2%
-82.2%
两年增速更快
RIGL
近两年复合增速
-0.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $37.7M | $69.8M |
| 净利润 | $-31.0M | $268.1M |
| 毛利率 | 32.1% | 91.5% |
| 营业利润率 | 7.6% | 33.2% |
| 净利率 | -82.2% | 384.0% |
| 营收同比 | -1.9% | 21.2% |
| 净利润同比 | -287.2% | 1769.2% |
| 每股收益（稀释后） | $-0.63 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NLRIGL
| Q4 25 | $37.7M | $69.8M | ||
| Q3 25 | $40.0M | $69.5M | ||
| Q2 25 | $40.4M | $101.7M | ||
| Q1 25 | $40.3M | $53.3M | ||
| Q4 24 | $38.4M | $57.6M | ||
| Q3 24 | $33.7M | $55.3M | ||
| Q2 24 | $35.9M | $36.8M | ||
| Q1 24 | $38.0M | $29.5M |
净利润NLRIGL
| Q4 25 | $-31.0M | $268.1M | ||
| Q3 25 | $-7.9M | $27.9M | ||
| Q2 25 | $355.0K | $59.6M | ||
| Q1 25 | $667.0K | $11.4M | ||
| Q4 24 | $16.5M | $14.3M | ||
| Q3 24 | $36.0M | $12.4M | ||
| Q2 24 | $7.8M | $-1.0M | ||
| Q1 24 | $6.8M | $-8.2M |
毛利率NLRIGL
| Q4 25 | 32.1% | 91.5% | ||
| Q3 25 | 27.6% | 93.2% | ||
| Q2 25 | 31.9% | 95.6% | ||
| Q1 25 | 30.2% | 91.7% | ||
| Q4 24 | 28.8% | 89.9% | ||
| Q3 24 | 28.1% | 85.5% | ||
| Q2 24 | 31.1% | 92.4% | ||
| Q1 24 | 25.5% | 93.1% |
营业利润率NLRIGL
| Q4 25 | 7.6% | 33.2% | ||
| Q3 25 | 4.6% | 40.9% | ||
| Q2 25 | 6.9% | 60.1% | ||
| Q1 25 | 7.8% | 23.9% | ||
| Q4 24 | 87.7% | 28.9% | ||
| Q3 24 | 6.0% | 25.4% | ||
| Q2 24 | 2.2% | 1.2% | ||
| Q1 24 | 3.6% | -23.6% |
净利率NLRIGL
| Q4 25 | -82.2% | 384.0% | ||
| Q3 25 | -19.7% | 40.2% | ||
| Q2 25 | 0.9% | 58.6% | ||
| Q1 25 | 1.7% | 21.5% | ||
| Q4 24 | 43.1% | 24.9% | ||
| Q3 24 | 107.0% | 22.5% | ||
| Q2 24 | 21.8% | -2.8% | ||
| Q1 24 | 18.0% | -27.9% |
每股收益（稀释后）NLRIGL
| Q4 25 | $-0.63 | $14.11 | ||
| Q3 25 | $-0.16 | $1.46 | ||
| Q2 25 | $0.01 | $3.28 | ||
| Q1 25 | $0.01 | $0.63 | ||
| Q4 24 | $0.34 | $0.82 | ||
| Q3 24 | $0.74 | $0.70 | ||
| Q2 24 | $0.16 | $-0.06 | ||
| Q1 24 | $0.14 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $110.6M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $358.8M | $391.5M |
| 总资产 | $464.2M | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资NLRIGL
| Q4 25 | $110.6M | $155.0M | ||
| Q3 25 | $101.9M | $137.1M | ||
| Q2 25 | $111.5M | $108.4M | ||
| Q1 25 | $110.0M | $77.1M | ||
| Q4 24 | $163.2M | $77.3M | ||
| Q3 24 | $146.0M | $61.1M | ||
| Q2 24 | $179.4M | $49.1M | ||
| Q1 24 | $167.9M | $49.5M |
总债务NLRIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益NLRIGL
| Q4 25 | $358.8M | $391.5M | ||
| Q3 25 | $375.4M | $117.6M | ||
| Q2 25 | $397.6M | $81.9M | ||
| Q1 25 | $397.6M | $18.6M | ||
| Q4 24 | $396.9M | $3.3M | ||
| Q3 24 | $386.0M | $-14.6M | ||
| Q2 24 | $373.1M | $-29.9M | ||
| Q1 24 | $368.1M | $-31.7M |
总资产NLRIGL
| Q4 25 | $464.2M | $513.6M | ||
| Q3 25 | $500.2M | $242.5M | ||
| Q2 25 | $523.7M | $206.7M | ||
| Q1 25 | $520.0M | $176.0M | ||
| Q4 24 | $578.3M | $164.0M | ||
| Q3 24 | $585.6M | $139.4M | ||
| Q2 24 | $580.0M | $128.4M | ||
| Q1 24 | $568.8M | $126.5M |
负债/权益比NLRIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-4.2M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $-4.7M | — |
| 自由现金流率自由现金流/营收 | -12.6% | — |
| 资本支出强度资本支出/营收 | 1.6% | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | $-40.1M | — |
8季度趋势，按日历期对齐
经营现金流NLRIGL
| Q4 25 | $-4.2M | $22.0M | ||
| Q3 25 | $7.9M | $24.0M | ||
| Q2 25 | $7.3M | $30.5M | ||
| Q1 25 | $-47.5M | $-893.0K | ||
| Q4 24 | $9.0M | $14.5M | ||
| Q3 24 | $-5.7M | $21.7M | ||
| Q2 24 | $15.5M | $302.0K | ||
| Q1 24 | $6.7M | $-5.0M |
自由现金流NLRIGL
| Q4 25 | $-4.7M | — | ||
| Q3 25 | $7.0M | — | ||
| Q2 25 | $5.9M | — | ||
| Q1 25 | $-48.3M | — | ||
| Q4 24 | $8.7M | — | ||
| Q3 24 | $-6.1M | — | ||
| Q2 24 | $15.1M | — | ||
| Q1 24 | $6.4M | — |
自由现金流率NLRIGL
| Q4 25 | -12.6% | — | ||
| Q3 25 | 17.4% | — | ||
| Q2 25 | 14.7% | — | ||
| Q1 25 | -119.9% | — | ||
| Q4 24 | 22.8% | — | ||
| Q3 24 | -18.3% | — | ||
| Q2 24 | 42.1% | — | ||
| Q1 24 | 17.0% | — |
资本支出强度NLRIGL
| Q4 25 | 1.6% | — | ||
| Q3 25 | 2.5% | — | ||
| Q2 25 | 3.3% | — | ||
| Q1 25 | 2.0% | — | ||
| Q4 24 | 0.6% | — | ||
| Q3 24 | 1.4% | — | ||
| Q2 24 | 1.2% | — | ||
| Q1 24 | 0.8% | — |
现金转化率NLRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | 20.53× | 0.51× | ||
| Q1 25 | -71.18× | -0.08× | ||
| Q4 24 | 0.54× | 1.01× | ||
| Q3 24 | -0.16× | 1.75× | ||
| Q2 24 | 1.98× | — | ||
| Q1 24 | 0.99× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NL
| Security Products | $29.5M | 78% |
| Marine Components | $8.2M | 22% |
RIGL
暂无分部数据
